FILAMENT HEALTH REPORTS Q4 AND YEAR END 2023 FINANCIAL RESUL

VANCOUVER, BC, April 2, 2024 /CNW/ - Filament Health Corp. , a clinical-stage natural psychedelic drug development company, released its fourth quarter financial results and operational highlights...

Related Keywords

United States , Canada , Perth , Western Australia , Australia , Israel , Belgium , United Kingdom , Vancouver , British Columbia , Canadian , British , Steven Nguyen , Magdalena Biosciences , Benjamin Lightburn , Michael Messinger , Drug Administration , Filament Health , Johns Hopkins University , Jupiter Acquisition Corporation , Sciences Ltd , Filament Health Corp , Audit Committee , Instagram , Jaguar Health Inc , University Of British Columbia , Linkedin , Twitter , Hadassah University Hospital , Health Canada , Chief Executive Officer , Jaguar Health , Metro Vancouver , Corporate Activities Subsequent , Investigational New Drug , University Hospital , Interim Chief Financial , Canada Newswire , Markets ,